Individualized antianginal therapy guided by systemic arterial pressure

Adam Schneeweiss; Leonardo Reisin

doi:10.1016/0002-9149(90)91302-M

Individualized antianginal therapy guided by systemic arterial pressure

Adam Schneeweiss
, Leonardo Reisin

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Abstract

All antianginal drugs except nitrates are also first-line antihypertensive drugs. Their antianginal efficacy has not been evaluated in relation to pretreatment blood pressure. They may aggravate ischemia due to excessive reduction in blood pressure. Until the results of direct comparative studies are available, it is advisable to start treatment of angina pectoris in normotensive and hypotensive patients with other drugs that do not primarily decrease blood pressure. Nitrates are a reasonable choice.

Original language	English
Pages (from-to)	J2-J5
Journal	American Journal of Cardiology
Volume	65
Issue number	21
DOIs	https://doi.org/10.1016/0002-9149(90)91302-M
State	Published - 4 Jun 1990
Externally published	Yes

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Access to Document

10.1016/0002-9149(90)91302-M

Cite this

@article{fdacc23919504d8fa35f55c63a9a22be,

title = "Individualized antianginal therapy guided by systemic arterial pressure",

abstract = "All antianginal drugs except nitrates are also first-line antihypertensive drugs. Their antianginal efficacy has not been evaluated in relation to pretreatment blood pressure. They may aggravate ischemia due to excessive reduction in blood pressure. Until the results of direct comparative studies are available, it is advisable to start treatment of angina pectoris in normotensive and hypotensive patients with other drugs that do not primarily decrease blood pressure. Nitrates are a reasonable choice.",

author = "Adam Schneeweiss and Leonardo Reisin",

year = "1990",

month = jun,

day = "4",

doi = "10.1016/0002-9149(90)91302-M",

language = "English",

volume = "65",

pages = "J2--J5",

journal = "American Journal of Cardiology",

issn = "0002-9149",

publisher = "Elsevier Inc.",

number = "21",

}

TY - JOUR

T1 - Individualized antianginal therapy guided by systemic arterial pressure

AU - Schneeweiss, Adam

AU - Reisin, Leonardo

PY - 1990/6/4

Y1 - 1990/6/4

N2 - All antianginal drugs except nitrates are also first-line antihypertensive drugs. Their antianginal efficacy has not been evaluated in relation to pretreatment blood pressure. They may aggravate ischemia due to excessive reduction in blood pressure. Until the results of direct comparative studies are available, it is advisable to start treatment of angina pectoris in normotensive and hypotensive patients with other drugs that do not primarily decrease blood pressure. Nitrates are a reasonable choice.

AB - All antianginal drugs except nitrates are also first-line antihypertensive drugs. Their antianginal efficacy has not been evaluated in relation to pretreatment blood pressure. They may aggravate ischemia due to excessive reduction in blood pressure. Until the results of direct comparative studies are available, it is advisable to start treatment of angina pectoris in normotensive and hypotensive patients with other drugs that do not primarily decrease blood pressure. Nitrates are a reasonable choice.

UR - https://www.scopus.com/pages/publications/0025369945

U2 - 10.1016/0002-9149(90)91302-M

DO - 10.1016/0002-9149(90)91302-M

M3 - Article

C2 - 1971990

AN - SCOPUS:0025369945

SN - 0002-9149

VL - 65

SP - J2-J5

JO - American Journal of Cardiology

JF - American Journal of Cardiology

IS - 21

ER -

Individualized antianginal therapy guided by systemic arterial pressure

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this